Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

10.1245/ASO.2005.07.022
Annals of Surgical Oncology 12:1066-1072 (2005)
© 2005 Society of Surgical Oncology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smidt, M. L.
Right arrow Articles by Strobbe, L. J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smidt, M. L.
Right arrow Articles by Strobbe, L. J. A.

Original Article

Can the Memorial Sloan-Kettering Cancer Center Nomogram Predict the Likelihood of Nonsentinel Lymph Node Metastases in Breast Cancer Patients in The Netherlands?

Marjolein L. Smidt, MD1, Deborah M. Kuster, MD1, Gert Jan van der Wilt, PhD2, Frederik B. Thunnissen, MD, PhD3, Kimberley J. Van Zee, MD4 and Luc J. A. Strobbe, MD, PhD1

1 Department of Surgical Oncology, C22, Canisius Wilhelmina Hospital, P.O. Box 9015, 6500 GS, Nijmegen, The Netherlands
2 Department of Medical Technology Assessment, Radboud University Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands
3 Department of Pathology, Canisius Wilhelmina Hospital, P.O. Box 9015, 6500 GS, Nijmegen, The Netherlands
4 Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021

Correspondence: Address correspondence and reprint requests to: Marjolein L. Smidt, MD; E-mail: marjoleinsmidt{at}yahoo.com.

Background: According to Dutch guidelines, an axillary lymph node dissection (ALND) is recommended whenever a sentinel lymph node (SLN) contains metastatic disease. However, only in approximately 50% of patients with metastatic disease in the SLN are additional nodal metastases detected in the completion ALND. To identify the individual patient’s risk for non-SLN metastases, a nomogram containing eight predictors was developed by the Breast Service of Memorial Sloan-Kettering Cancer Center (New York, NY). The aim of this study was to test the accuracy of the nomogram on a population of Dutch breast cancer patients.

Methods: Patient, tumor, and SLN metastasis characteristics were collected for 222 consecutive patients who underwent a completion ALND. The data of the index and test populations were compared. A receiver operating characteristic curve was drawn, and the area under the curve was calculated to assess the discriminative power of the nomogram.

Results: Even though our patient population differed in many respects from the source population, the area under the receiver operating characteristic curve amounted to .77, a value very much comparable to the one found in the source population.

Conclusions: The nomogram provides a fairly accurate predicted probability for the likelihood of non-SLN metastases in a general population of breast cancer patients at a regional teaching hospital in The Netherlands. This suggests that the nomogram’s originally calculated predictive accuracy may be valid for patient populations that differ considerably from the population in which it was developed.

Key Words: Breast neoplasms • Sentinel lymph node biopsy • Nomogram • Axillary metastases • Prediction




This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
E. Poirier, L. Sideris, P. Dube, P. Drolet, and S. H. Meterissian
Analysis of Clinical Applicability of the Breast Cancer Nomogram for Positive Sentinel Lymph Node: The Canadian Experience
Ann. Surg. Oncol., September 1, 2008; 15(9): 2562 - 2567.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
S. Samphao, J. M. Eremin, M. El-Sheemy, and O. Eremin
Management of the Axilla in Women With Breast Cancer: Current Clinical Practice and a New Selective Targeted Approach
Ann. Surg. Oncol., May 1, 2008; 15(5): 1282 - 1296.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
K. J. Van Zee and M. W. Kattan
Validating a Predictive Model for Presence of Additional Disease in the Non Sentinel Lymph Nodes of a Woman with Sentinel Node Positive Breast Cancer
Ann. Surg. Oncol., August 1, 2007; 14(8): 2177 - 2178.
[Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
C. E. Dauphine, J. S. Haukoos, M. P. Vargas, N. M. Isaac, I. Khalkhali, and H. I. Vargas
Evaluation of Three Scoring Systems Predicting Non Sentinel Node Metastasis in Breast Cancer Patients with a Positive Sentinel Node Biopsy
Ann. Surg. Oncol., March 1, 2007; 14(3): 1014 - 1019.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
G. Houvenaeghel, C. Nos, H. Mignotte, J. M. Classe, S. Giard, P. Rouanet, F. P. Lorca, J. Jacquemier, and V. J. Bardou
Micrometastases in Sentinel Lymph Node in a Multicentric Study: Predictive Factors of Nonsentinel Lymph Node Involvement--Groupe Des Chirurgiens De La Federation Des Centres De Lutte Contre Le Cancer
J. Clin. Oncol., April 20, 2006; 24(12): 1814 - 1822.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
H. Mabry and A. E. Giuliano
The Practical Value of Prediction: A Semireliable Assistant
Ann. Surg. Oncol., March 1, 2006; 13(3): 282 - 284.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Society of Surgical Oncology.